Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Detecting and predicting neutralization of alemtuzumab responses in MS.
Saxena G, Moore JM, Jones M, Pryce G, Ali L, Leisegang GR, Vijay V, Loveless S, Robertson NP, Schmierer K, Giovannoni G, Gnananpavan S, Baker D, Tallantyre EC, Kang AS. Saxena G, et al. Among authors: schmierer k. Neurol Neuroimmunol Neuroinflamm. 2020 Jun 4;7(4):e767. doi: 10.1212/NXI.0000000000000767. Print 2020 Jul. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 32499328 Free PMC article.
Assessing treatment response to interferon-β: is there a role for MRI?
Dobson R, Rudick RA, Turner B, Schmierer K, Giovannoni G. Dobson R, et al. Among authors: schmierer k. Neurology. 2014 Jan 21;82(3):248-54. doi: 10.1212/WNL.0000000000000036. Epub 2013 Dec 11. Neurology. 2014. PMID: 24336144 Free PMC article. Review.
Simvastatin in patients with progressive multiple sclerosis.
Giovannoni G, Baker D, Schmierer K. Giovannoni G, et al. Among authors: schmierer k. Lancet. 2014 Sep 13;384(9947):952. doi: 10.1016/S0140-6736(14)61621-4. Lancet. 2014. PMID: 25220965 No abstract available.
Association of British Neurologists: revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis.
Scolding N, Barnes D, Cader S, Chataway J, Chaudhuri A, Coles A, Giovannoni G, Miller D, Rashid W, Schmierer K, Shehu A, Silber E, Young C, Zajicek J. Scolding N, et al. Among authors: schmierer k. Pract Neurol. 2015 Aug;15(4):273-9. doi: 10.1136/practneurol-2015-001139. Epub 2015 Jun 22. Pract Neurol. 2015. PMID: 26101071 No abstract available.
Is it time to target no evident disease activity (NEDA) in multiple sclerosis?
Giovannoni G, Turner B, Gnanapavan S, Offiah C, Schmierer K, Marta M. Giovannoni G, et al. Among authors: schmierer k. Mult Scler Relat Disord. 2015 Jul;4(4):329-33. doi: 10.1016/j.msard.2015.04.006. Epub 2015 May 8. Mult Scler Relat Disord. 2015. PMID: 26195051 Free article. Review.
159 results